Multistep laryngeal carcinogenesis helps our understanding of the field cancerisation phenomenon: a review

被引:35
作者
Almadori, G [1 ]
Bussu, F [1 ]
Cadoni, G [1 ]
Galli, J [1 ]
Rigante, M [1 ]
Artuso, A [1 ]
Maurizi, M [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Inst Otolaryngol, I-00168 Rome, Italy
关键词
larynx; head and neck; cancer; multistep carcinogenesis; field cancerisation;
D O I
10.1016/j.ejca.2004.04.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this paper, we try to briefly review the most recent knowledge on head and neck cancer, and especially multistep laryngeal carcinogenesis, and to simply explain how this has modified our understanding of field cancerisation phenomenon. Experimental studies, made possible by the recent evolution of microdissection systems, have demonstrated that the 'spatial progression' of the histopathological phenotype in the surroundings of malignant or premalignant head and neck lesions correlates with molecular progression. Such a 'spatial progression' can be hypothesised to reflect temporal progression. The field cancerisation process has been divided into three phases, each with its own histological and molecular characteristics. Each of these phases may have clinical implications: detection and monitoring of fields may help cancer prevention (molecular epidemiology), early detection of recurrence (or, more exactly, of second field tumours (SFTs)) (molecular diagnostics) and prognostic prediction after treatment. This model appears plausible, especially in explaining the development of multiple primary tumours (MPTs) in adjacent head and neck mucosal regions, with peculiar clinical and prognostic implications: These tumours can be defined as multiple field tumours (SFTs). However, the model, in our opinion, does not convincingly explain the development of second primary tumours (SPTs) at more distant sites, such as the lung, colon and prostate. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2383 / 2388
页数:6
相关论文
共 38 条
[1]   Detection of human papillomavirus DNA in laryngeal squamous cell carcinoma by polymerase chain reaction [J].
Almadori, G ;
Cadoni, G ;
Cattani, P ;
Posteraro, P ;
Scarano, E ;
Ottaviani, F ;
Paludetti, G ;
Maurizi, M .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (05) :783-788
[2]   Serum folate and homocysteine levels in head and neck squamous cell carcinoma [J].
Almadori, G ;
Bussu, F ;
Galli, J ;
Cadoni, G ;
Zappacosta, B ;
Persichilli, S ;
Minucci, A ;
Giardina, B .
CANCER, 2002, 94 (04) :1006-1011
[3]  
Almadori G, 2001, CLIN CANCER RES, V7, P3988
[4]  
Bellacosa A, 1996, CLIN CANCER RES, V2, P175
[5]  
BOYLE JO, 1993, CANCER RES, V53, P4477
[6]  
Braakhuis BJM, 2003, CANCER RES, V63, P1727
[7]   Unknown primary head and neck squamous cell carcinoma: Molecular identification of the site of origin [J].
Califano, J ;
Westra, WH ;
Koch, W ;
Meininger, G ;
Reed, A ;
Yip, L ;
Boyle, JO ;
Lonardo, F ;
Sidransky, D .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (07) :599-604
[8]  
Califano J, 1996, CANCER RES, V56, P2488
[9]  
Califano J, 2000, CLIN CANCER RES, V6, P347
[10]  
Cattani P, 1998, CLIN CANCER RES, V4, P2585